{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:38:55Z","timestamp":1786451935705,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K09517"],"award-info":[{"award-number":["22K09517"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09664"],"award-info":[{"award-number":["19K09664"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"crossref","award":["JPMJPF2017"],"award-info":[{"award-number":["JPMJPF2017"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55807-z","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:53:41Z","timestamp":1780289621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-overexpression of ELOVL2 and ELOVL5 promotes clear cell renal cell carcinoma progression through LIMK1-mediated cytoskeletal reorganization"],"prefix":"10.1038","volume":"16","author":[{"given":"Shotaro","family":"Sakka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Kandori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozaburo","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Nagumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Ferdousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsuzaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"55807_CR1","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers. 3, 17009 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"55807_CR2","first-page":"507","volume":"67","author":"PC Barata","year":"2017","unstructured":"Barata, P. C. & Rini, B. I. Treatment of renal cell carcinoma: Current status and future directions. CA Cancer J. Clin. 67, 507\u2013524 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"55807_CR3","doi-asserted-by":"publisher","first-page":"102745","DOI":"10.1016\/j.ctrv.2024.102745","volume":"127","author":"M Tucci","year":"2024","unstructured":"Tucci, M. et al. Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials. Cancer Treat. Rev. 127, 102745 (2024).","journal-title":"Cancer Treat. Rev."},{"key":"55807_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","volume":"45","author":"AR Terry","year":"2024","unstructured":"Terry, A. R. & Hay, N. Emerging targets in lipid metabolism for cancer therapy. Trends Pharmacol. Sci. 45, 537\u2013551 (2024).","journal-title":"Trends Pharmacol. Sci."},{"key":"55807_CR5","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia, S. et al. Lipid metabolic reprogramming in cancer cells. Oncogenesis 5, e189 (2016).","journal-title":"Oncogenesis"},{"key":"55807_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.plipres.2009.12.002","volume":"49","author":"H Guillou","year":"2010","unstructured":"Guillou, H. et al. The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res. 49, 186\u2013199 (2010).","journal-title":"Prog Lipid Res."},{"key":"55807_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer. 122, 4\u201322 (2020).","journal-title":"Br. J. Cancer"},{"key":"55807_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/metabo10120509","volume":"10","author":"G Lucarelli","year":"2020","unstructured":"Lucarelli, G. et al. Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma. Metabolites 10, 509 (2020).","journal-title":"Metabolites"},{"key":"55807_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/or.2021.8234","volume":"47","author":"K Tanaka","year":"2022","unstructured":"Tanaka, K. et al. ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma. Oncol. Rep. 47, 23 (2022).","journal-title":"Oncol. Rep."},{"key":"55807_CR10","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/cas.15454","volume":"113","author":"S Nitta","year":"2022","unstructured":"Nitta, S. et al. ELOVL5-mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma. Cancer Sci. 113, 2738\u20132752 (2022).","journal-title":"Cancer Sci."},{"key":"55807_CR11","first-page":"385","volume":"9","author":"J Aseervatham","year":"2020","unstructured":"Aseervatham, J. Cytoskeletal remodeling in cancer. Biology (Basel). 9, 385 (2020).","journal-title":"Biology (Basel)"},{"key":"55807_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/bs.ircmb.2020.09.004","volume":"360","author":"C Mondal","year":"2021","unstructured":"Mondal, C., Di Martino, J. S. & Bravo-Cordero, J. J. Actin dynamics during tumor cell dissemination. Int. Rev. Cell. Mol. Biol. 360, 65\u201398 (2021).","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"55807_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","volume":"1773","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi, H. & Condeelis, J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta. 1773, 642\u2013652 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"55807_CR14","doi-asserted-by":"publisher","first-page":"021307","DOI":"10.1063\/5.0198119","volume":"5","author":"JP Conboy","year":"2024","unstructured":"Conboy, J. P. et al. How cytoskeletal crosstalk makes cells move: Bridging cell-free and cell studies. Biophys. Rev. (Melville). 5, 021307 (2024).","journal-title":"Biophys. Rev. (Melville)"},{"key":"55807_CR15","first-page":"4050","volume":"11","author":"P Gibieza","year":"2021","unstructured":"Gibieza, P. & Petrikaite, V. The regulation of actin dynamics during cell division and malignancy. Am. J. Cancer Res. 11, 4050\u20134069 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"55807_CR16","doi-asserted-by":"publisher","first-page":"151315","DOI":"10.1016\/j.ejcb.2023.151315","volume":"102","author":"E Jeruzalska","year":"2023","unstructured":"Jeruzalska, E. & Mazur, A. J. The role of non-muscle actin paralogs in cell cycle progression and proliferation. Eur. J. Cell. Biol. 102, 151315 (2023).","journal-title":"Eur. J. Cell. Biol."},{"key":"55807_CR17","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1080\/15384101.2014.998085","volume":"14","author":"N Bendris","year":"2015","unstructured":"Bendris, N. et al. Cell cycle, cytoskeleton dynamics and beyond: The many functions of cyclins and CDK inhibitors. Cell. Cycle. 14, 1786\u20131798 (2015).","journal-title":"Cell. Cycle"},{"key":"55807_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature08908","volume":"463","author":"DA Fletcher","year":"2010","unstructured":"Fletcher, D. A. & Mullins, R. D. Cell mechanics and the cytoskeleton. Nature 463, 485\u2013492 (2010).","journal-title":"Nature"},{"key":"55807_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/31729","volume":"393","author":"S Arber","year":"1998","unstructured":"Arber, S. et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393, 805\u2013809 (1998).","journal-title":"Nature"},{"key":"55807_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/cells12050805","volume":"12","author":"E Villalonga","year":"2023","unstructured":"Villalonga, E. et al. LIM kinases, LIMK1 and LIMK2, are crucial node actors of the cell fate: Molecular to pathological features. Cells 12, 805 (2023).","journal-title":"Cells"},{"key":"55807_CR21","doi-asserted-by":"publisher","first-page":"36868","DOI":"10.1074\/jbc.M306196200","volume":"278","author":"M Davila","year":"2003","unstructured":"Davila, M. et al. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: Implications in prostate cancer. J. Biol. Chem. 278, 36868\u201336875 (2003).","journal-title":"J. Biol. Chem."},{"key":"55807_CR22","doi-asserted-by":"publisher","first-page":"216420","DOI":"10.1016\/j.canlet.2023.216420","volume":"576","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation. Cancer Lett. 576, 216420 (2023).","journal-title":"Cancer Lett."},{"key":"55807_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1158\/1535-7163.MCT-14-0447","volume":"14","author":"K Mardilovich","year":"2015","unstructured":"Mardilovich, K. et al. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation. Mol. Cancer Ther. 14, 246\u2013258 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"55807_CR24","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1073\/pnas.1232344100","volume":"100","author":"K Yoshioka","year":"2003","unstructured":"Yoshioka, K. et al. A role for LIM kinase in cancer invasion. Proc. Natl. Acad. Sci. USA. 100, 7247\u20137252 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"55807_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.biopha.2014.11.011","volume":"69","author":"T You","year":"2015","unstructured":"You, T. et al. Overexpression of LIMK1 promotes tumor growth and metastasis in gastric cancer. Biomed. Pharmacother. 69, 96\u2013101 (2015).","journal-title":"Biomed. Pharmacother"},{"key":"55807_CR26","doi-asserted-by":"publisher","first-page":"45624","DOI":"10.1038\/srep45624","volume":"7","author":"J Su","year":"2017","unstructured":"Su, J. et al. Downregulation of LIMK1-ADF\/cofilin by DADS inhibits the migration and invasion of colon cancer. Sci. Rep. 7, 45624 (2017).","journal-title":"Sci. Rep."},{"key":"55807_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11010-013-1959-1","volume":"390","author":"L Wan","year":"2014","unstructured":"Wan, L. et al. MiR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells. Mol. Cell. Biochem. 390, 85\u201391 (2014).","journal-title":"Mol. Cell. Biochem."},{"key":"55807_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-018-0127-8","volume":"24","author":"B Shi","year":"2019","unstructured":"Shi, B. et al. MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells. Cell. Mol. Biol. Lett. 24, 1 (2019).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"55807_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1593\/neo.04514","volume":"7","author":"I Okamoto","year":"2005","unstructured":"Okamoto, I. et al. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia 7, 303\u2013311 (2005).","journal-title":"Neoplasia"},{"key":"55807_CR30","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1194\/jlr.M090712","volume":"60","author":"H Yamada","year":"2019","unstructured":"Yamada, H. et al. Effect of fatty acids on melanogenesis and tumor cell growth in melanoma cells. J. Lipid Res. 60, 1491\u20131502 (2019).","journal-title":"J. Lipid Res."},{"key":"55807_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.yjmcc.2014.05.008","volume":"74","author":"W Witt","year":"2014","unstructured":"Witt, W. et al. Reversal of myofibroblastic activation by polyunsaturated fatty acids in valvular interstitial cells from aortic valves: Role of RhoA\/G-actin\/MRTF signalling. J. Mol. Cell. Cardiol. 74, 127\u2013138 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"55807_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cub.2011.03.039","volume":"21","author":"JJ Bravo-Cordero","year":"2011","unstructured":"Bravo-Cordero, J. J. et al. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr. Biol. 21, 635\u2013644 (2011).","journal-title":"Curr. Biol."},{"key":"55807_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2015.00004","volume":"3","author":"A Jacob","year":"2015","unstructured":"Jacob, A. & Prekeris, R. The regulation of MMP targeting to invadopodia during cancer metastasis. Front. Cell. Dev. Biol. 3, 4 (2015).","journal-title":"Front. Cell. Dev. Biol."},{"key":"55807_CR34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-19-0061","volume":"9","author":"RC Gimple","year":"2019","unstructured":"Gimple, R. C. et al. Glioma stem cell-specific superenhancer promotes polyunsaturated fatty-acid synthesis to support EGFR signaling. Cancer Discov. 9, 1248\u20131267 (2019).","journal-title":"Cancer Discov"},{"key":"55807_CR35","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/cells11132090","volume":"11","author":"R Berabez","year":"2022","unstructured":"Berabez, R. et al. LIM kinases, promising but reluctant therapeutic targets: Chemistry and preclinical validation in vivo. Cells 11, 2090 (2022).","journal-title":"Cells"},{"key":"55807_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","volume":"73","author":"GP Paner","year":"2018","unstructured":"Paner, G. P. et al. Updates in the Eighth Edition of the Tumor-Node-Metastasis staging classification for urologic cancers. Eur. Urol. 73, 560\u2013569 (2018).","journal-title":"Eur. Urol."},{"key":"55807_CR37","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/cas.13609","volume":"109","author":"S Kandori","year":"2018","unstructured":"Kandori, S. et al. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin. Cancer Sci. 109, 1865\u20131875 (2018).","journal-title":"Cancer Sci."},{"key":"55807_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbrc.2011.08.088","volume":"413","author":"H Watanabe","year":"2011","unstructured":"Watanabe, H. et al. Phospholipase D2 activation by p38 MAP kinase is involved in neurite outgrowth. Biochem. Biophys. Res. Commun. 413, 288\u2013293 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"55807_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"55807_CR40","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"55807_CR41","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman, R. L. et al. Toward a shared vision for cancer genomic data. N Engl. J. Med. 375, 1109\u20131112 (2016).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55807-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55807-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55807-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:05:15Z","timestamp":1786449915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55807-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55807"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55807-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24838"}}